Expanding Diagnostic Tools for iRBD Through Actigraphy-Based Classifiers

Emmanuel During, MD, an associate professor of neurology at the Icahn School of Medicine at Mount Sinai, discussed the external validation of an actigraphy-based classifier for diagnosing iRBD and its implications for scalable neurodegenerative screening.:

Source: Neurology Read More